epocrates logo
epocrates logo
epocrates logo
  • 0

Diseases

Evaluation of hypokalemia

OVERVIEW

  • Summary
  • Urgent Considerations
  • Etiology

DIAGNOSIS

  • Differential Diagnosis
  • Diagnostic Approach

IMAGES

  • Library

REFERENCES

  • Citations
  • Credits

Summary

AAFont SizeShareMore Information
Hypokalemia is defined as a serum potassium level <3.5 mEq/L. Moderate hypokalemia is defined as serum potassium levels of 2.5 to 3 mEq/L and severe hypokalemia defined as a serum potassium level <2.5 mEq/L.[1] The ratio of intracellular to extracellular potassium determines, in part, the cellular membrane potential. Therefore small changes in the extracellular potassium level can have large effects on the function of the cardiovascular and neuromuscular systems.
Hypokalemia is most commonly due to urinary or GI losses. A fall in serum potassium from 4.0 to 3.0 mEq/L represents an approximate loss of 200 to 400 mEq of potassium. However, these estimates do not always apply to patients with transcellular potassium redistribution. Clinical manifestations of hypokalemia are typically seen only if the serum potassium is <3.0 mEq/L.
Common acute manifestations are muscle weakness and ECG changes. More prolonged and profound hypokalemia may cause rhabdomyolysis, renal abnormalities, and cardiac arrhythmias.
The rapidity and method of potassium repletion depends on the:
  • severity of hypokalemia

  • presence of associated conditions

  • presence or absence of signs and symptoms

  • expectation of continued losses.

Obtaining an ECG is recommended for all patients with hypokalemia. Frequent monitoring of the serum potassium concentration is also recommended to ensure appropriate repletion and to avoid hyperkalemia.
content by BMJ Group
Last updated

Library

  • Causes of increased potassium excretion

    Causes of increased potassium excretion

  • 12-lead ECG demonstrating prominent U-waves in a patient with hypokalemia

    12-lead ECG demonstrating prominent U-waves in a patient with hypokalemia

  • Algorithm to determine the cause of hypokalemia

    Algorithm to determine the cause of hypokalemia

Citations

    Key Articles

    • Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011;7:75-84.[Abstract]

    • Pepin J, Shields C. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract. 2012;14:1-17.[Abstract]

    • Greenlee M, Wingo CS, McDonough AA, et al. Narrative review: evolving concepts in potassium homeostasis and hypokalemia. Ann Intern Med. 2009;150:619-625.[Abstract]

    Referenced Articles

    • 1. Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011;7:75-84.[Abstract]

    • 2. Schrier RW, ed. Renal and electrolyte disorders, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003.

    • 3. Liu T, Nagami GT, Everett ML, et al. Very low calorie diets and hypokalaemia: the importance of ammonium excretion. Nephrol Dial Transplant. 2005;20:642-646.[Abstract][Full Text]

    • 4. Clausen T, Flatman JA. Effect of insulin and epinephrine on Na+-K+-ATPase and glucose transport in soleus muscle. Am J Physiol. 1987;252:E492-E499.[Abstract]

    • 5. Shannon M, Lovejoy FH. Hypokalemia after theophylline intoxication. The effects of acute vs chronic poisoning. Arch Intern Med. 1989;149:2725-2729.[Abstract]

    • 6. Morgan DB, Young RM. Acute transient hypokalemia: a new interpretation of a common event. Lancet. 1982;2:751-752.[Abstract]

    • 7. Adrogue HJ, Lederer ED, Suki WN, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986;65:163-172.[Abstract]

    • 8. Fontaine B, Lapie P, Plassart E, et al. Periodic paralysis and voltage-gated ion channels. Kidney Int. 1996;49:9-18.[Abstract]

    • 9. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999;159:601-606.[Abstract][Full Text]

    • 10. Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006;91:2490-2495.[Abstract][Full Text]

    • 11. Rose BD, Post TW. Clinical physiology of acid-base and electrolyte disorders, 5th ed. New York, NY: McGraw-Hill; 2001:836-856.

    • 12. Clemessy JL, Favier C, Borron SW, et al. Hypokalaemia related to acute chloroquine ingestion. Lancet. 1995;346:877-880.[Abstract]

    • 13. Buse S, Blancher M, Viglino D, et al. The impact of hypothermia on serum potassium concentration: A systematic review. Resuscitation. 2017 Sep;118:35-42.[Abstract][Full Text]

    • 14. Ravipati P, Murray S, Yannopoulos D, et al. Impact of AKI in patients with out-of-hospital cardiac arrest managed with VA ECMO. Kidney360. 2021 Nov 25;2(11):1827-30.[Abstract][Full Text]

    • 15. Older J, Older P, Colker J, et al. Secretory villous adenomas that cause depletion syndromes. Arch Intern Med. 1999;159:879-880.[Abstract]

    • 16. Agarwal R, Afzalpurkar R, Fordtran JS. Pathophysiology of potassium absorption and secretion by the human intestine. Gastroenterology. 1994;107:548-571.[Abstract]

    • 17. Curran MP, Plosker GL. Oral sodium phosphate solution: A review of its use as a colorectal cleanser. Drugs. 2004;64:1697-1714.[Abstract]

    • 18. Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab. 2003;88:2384-2392.[Abstract]

    • 19. Pepin J, Shields C. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract. 2012;14:1-17.[Abstract]

    • 20. Greenlee M, Wingo CS, McDonough AA, et al. Narrative review: evolving concepts in potassium homeostasis and hypokalemia. Ann Intern Med. 2009;150:619-625.[Abstract]

    • 21. Adamidis A, Cantas-Orsdemir S, Tsirka A, et al. Apparent Mineralocorticoid Excess in the Pediatric Population: Report of a Novel Pathogenic Variant of the 11beta-HSD2 Gene and Systematic Review of the Literature. Pediatr Endocrinol Rev. 2019 Mar;16(3):335-58.[Abstract][Full Text]

    • 22. Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 Jan;97(1):42-61.[Abstract][Full Text]

    • 23. Fan P, Lu YT, Yang KQ, et al. Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia. Endocrine. 2020 Dec;70(3):607-15.[Abstract][Full Text]

    • 24. McHugh J, Nagabathula R, Kyithar MP. A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion. BMC Endocr Disord. 2021 Aug 6;21(1):158.[Abstract][Full Text]

    • 25. Perazella MA, Eisen RN, Frederick WG, et al. Renal failure and severe hypokalemia associated with acute myelomonocytic leukemia. Am J Kidney Dis. 1993;22:462-467.[Abstract]

    • 26. Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 Jan;91(1):24-33.[Abstract][Full Text]

    • 27. Fulchiero R, Seo-Mayer P. Bartter Syndrome and Gitelman Syndrome. Pediatr Clin North Am. 2019 Feb;66(1):121-34.[Abstract][Full Text]

    • 28. Konrad M, Nijenhuis T, Ariceta G, et al. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders. Kidney Int. 2021 Feb;99(2):324-35.[Abstract][Full Text]

    • 29. Mohr JA, Clark RM, Waack TC, et al. Nafcillin-associated hypokalemia. JAMA. 1979;242:544.[Abstract]

    • 30. Carlisle EJ, Donnelly SM, Vasuvattakul S, et al. Glue-sniffing and distal renal tubular acidosis: Sticking to the facts. J Am Soc Nephrol. 1991;1:1019-1027.[Abstract][Full Text]

    • 31. Carlisle EJ, Donnelly SM, Ethier JH, et al. Modulation of the secretion of potassium by accompanying anions in humans. Kidney Int. 1991;39:1206-1212.[Abstract]

    • 32. Douglas JB, Healy JK. Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am J Med. 1969;46:154-162.[Abstract]

    • 33. Whang R, Whang DD, Ryan MP. Refractory potassium depletion. A consequence of magnesium deficiency. Arch Intern Med. 1992;152:40-45.[Abstract]

    • 34. US Department of Health and Human Services. National Institutes of Health. Magnesium: fact sheet for health professionals. June 2022 [internet publication].[Full Text]

    • 35. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007 Oct;18(10):2649-52.[Abstract][Full Text]

    • 36. Hariprasad MK, Eisinger RP, Nadler IM, et al. Hyponatremia in psychogenic polydipsia. Arch Intern Med. 1980;140:1639-1642.[Abstract]

    • 37. Godek SF, Godek JJ, Bartolozzi AR. Hydration status in college football players during consecutive days of twice-a-day preseason practices. Am J Sports Med. 2005;33:843-851.[Abstract]

    • 38. Dave S, Honney S, Raymond J, et al. An unusual presentation of cystic fibrosis in an adult. Am J Kidney Dis. 2005;45:e41-e44.[Abstract]

    • 39. Elisaf M, Liberopoulos E, Bairaktari E, et al. Hypokalaemia in alcoholic patients. Drug Alcohol Rev. 2002 Mar;21(1):73-6.[Abstract][Full Text]

    • 40. Rostand SG. Profound hypokalemia in continuous ambulatory peritoneal dialysis. Arch Intern Med. 1983;143:377-378.[Abstract]

    • 41. Córdoba JP, Larrarte C, Medina MC. Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: Registry of the first 500 sessions. J Clin Apher. 2015 Dec;30(6):347-52.[Abstract][Full Text]

    • 42. Orlin JB, Berkman EM. Partial plasma exchange using albumin replacement: Removal and recovery of normal plasma constituents. Blood. 1980;56:1055-1059.[Abstract][Full Text]

    • 43. Tetti M, Monticone S, Burrello J, et al. Liddle syndrome: review of the literature and description of a new case. Int J Mol Sci. 2018 Mar 11;19(3):812[Abstract][Full Text]

    • 44. Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018 Apr;7(4):R135-R146.[Abstract][Full Text]

    • 45. Martin KJ, González EA, Slatopolsky E. Clinical consequences and management of hypomagnesemia. J Am Soc Nephrol. 2009 Nov;20(11):2291-5.[Abstract][Full Text]

    • 46. Tsuji H, Venditti FJ Jr, Evans JC, et al. The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol. 1994;74:232-235.[Abstract]

    • 47. Riemenschneider T, Bohle A. Morphologic aspects of low-potassium and low-sodium nephropathy. Clin Nephrol. 1983;19:271-279.[Abstract]

    • 48. Chaudhry MA, Wayangankar S. Thyrotoxic Periodic Paralysis: A Concise Review of the Literature. Curr Rheumatol Rev. 2016;12(3):190-4.[Abstract][Full Text]

    • 49. Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024 Aug 1;47(8):1257-75.[Abstract][Full Text]

    • 50. Negrotto L, Barroso FA. Focal hypokalemic paralysis: Report of 2 cases and review of the literature. J Clin Neuromuscul Dis. 2012;14:21-27.[Abstract]

    • 51. Veltri KT, Mason C. Medication-induced hypokalemia. P T. 2015 Mar;40(3):185-90.[Abstract][Full Text]

    • 52. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009 Jul;32(7):1335-43.[Abstract][Full Text]

    • 53. Basok AB, Haviv YS, Rogachev B, et al. Renal tubular acidosis type I with prominent hypokalemia and nephrolithiasis as a presentation of Sjögren's/Systemic Lupus Erythematosus disease. Case Rep Nephrol Dial. 2021 May-Aug;11(2):247-53.[Abstract][Full Text]

    • 54. Vasquez-Rios G, Westrich DJ Jr, Philip I, et al. Distal renal tubular acidosis and severe hypokalemia: a case report and review of the literature. J Med Case Rep. 2019 Apr 26;13(1):103.[Abstract][Full Text]

    • 55. Barathidasan GS, Krishnamurthy S, Karunakar P, et al. Systemic lupus erythematosus complicated by a Gitelman-like syndrome in an 8-year-old girl. CEN Case Rep. 2020 May;9(2):129-32.[Abstract][Full Text]

    • 56. Sterns RH, Cox M, Feig PU, et al. Internal potassium balance and the control of the plasma potassium concentration. Medicine (Baltimore). 1981;60:339-354.[Abstract]

    • 57. Liamis G, Liberopoulos E, Barkas F, et al. Spurious electrolyte disorders: a diagnostic challenge for clinicians. Am J Nephrol. 2013;38(1):50-7.[Abstract][Full Text]

    • 58. Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-75.[Abstract][Full Text]

    • 59. Schwartz WB, Relman AS. Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives. J Clin Invest. 1953;32:258-271.[Abstract][Full Text]

    • 60. Oster JR, Materson BJ, Rogers AI. Laxative abuse syndrome. Am J Gastroenterol. 1980;74:451-458.[Abstract]

    • 61. Ewe K, Karbach U. Factitious diarrhea. Clin Gastroenterol. 1986;15:723-740.[Abstract]

    • 62. Carey RM. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach. Curr Cardiol Rep. 2016 Oct;18(10):97.[Abstract][Full Text]

    • 63. Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 May;101(5):1889-916.[Abstract][Full Text]

    • 64. Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med. 1993;153:2125-2129.[Abstract]

    • 65. Dominic JA, Koch M, Guthrie GP Jr., et al. Primary aldosteronism presenting as myoglobinuric acute renal failure. Arch Intern Med. 1978;138:1433-1434.[Abstract]

    • 66. Torpy DJ, Mullen N, Ilias I, et al. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci. 2002;970:134-144.[Abstract]

Have feedback?
Tell us about your experience
Scroll to Top
epocrates logo

Sign in to access our clinical decision support tools

Sign inCreate Account
Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information